Category Archives: Drug Companies

With over 1.5 million drug and medical device related injuries each year, consumers are forced to take legal action. Find out if you have a lawsuit. Read news stories about dangerous medical devices and prescription drugs, health studies and pharmaceutical litigation.

Monsanto Given Legal Shield in a Chemical Safety Bill

WASHINGTON — Facing hundreds of millions of dollars in lawsuits, the giant biotechnology companyMonsanto last year received a legislative gift from the House of Representatives, a one-paragraph addition to a sweeping chemical safety bill that could help shield it from legal liability for a toxic chemical only it made.

Monsanto insists it did not ask for the addition. House aides deny it is a gift at all. But the provision would benefitthe only manufacturer in the United States of now-banned polychlorinated biphenyls, chemicals known as PCBs, a mainstay of Monsanto sales for decades. The PCB provision is one of several sticking points that negotiators must finesse before Congress can pass a law to revamp the way thousands of chemicals are regulated in the United States.

“Call me a dreamer, but I wish for a Congress that would help cities with their homeless crises instead of protecting multinational corporations that poison our environment,” said Pete Holmes, the city attorney for Seattle, one of six cities suing Monsanto to help cover the costs of reducing PCB discharge from their sewers.

The House and the Senate last year both passed versions of legislation to replace the 40-year-old Toxic Substances Control Act, a law that theEnvironmental Protection Agency acknowledged had become so unworkable that as many as 1,000 hazardous chemicals still on sale today needed to be evaluated to see if they should be banned or restricted.

Democrats and Republicans—along with the chemical industry and even some environmentalists—agree that the pending legislation would be a major improvement over existing law.But from legal liability shields to state-based regulatory authority, the House and Senate versions have major differences to resolve. The remaining disputes revolve around the basics of pre-emption: Who gets to sue? Andwho gets to regulate the chemical industry?

A Monsanto spokeswoman said the company had received no special treatment from the House or the Senate.

“Monsanto does not consider either version of the bill, with respect to the effect on preemption, to be a ‘gift,’ ” the spokeswoman, Charla Lord, said.

Already, attorneys general and top environmental regulators from 15 states have written to leaders in Congress demanding changes.

“Our future work depends on striking the right balance to strengthen the U.S. Environmental Protection Agency’s abilities and funding, without limiting state powers in creating and enforcing needed protections,” said aletter, obtained by The New York Times, sent by the top environmental regulators in California, Connecticut, Minnesota, New Hampshire, New York, Oregon, Washington and West Virginia.

Screen Shot 2016-02-29 at 9.57.25 PM

Some of the most vociferous objections relate to the so-called Monsanto Clause. The provision does not mention the company by name, but between the early 1930s and 1977, Monsanto manufactured almost all of the 1.25 billion pounds of PCBs sold in the United States.

The chemicals were initially admired for their ability to prevent fires and explosions in electrical transformers and other equipment. But as the use of PCBs skyrocketed nationwide in products as varied as paints, pesticides and even carbonless copy paper, evidence mounted that they were contaminating the environment and potentially causing health problemsincluding cancer and immune-system complications. The E.P.A. banned their production in 1979.

PCB litigation has surged in the last year as cities and school systems struggle to comply with directives from federal and state regulators to reduce PCB levels in sewer discharge and in caulk once used to construct schools. Separately, a group of individuals who received diagnoses of a form of cancer known as non-Hodgkin’s lymphoma sued Monsanto last year, claiming the company should pay damages.

The Senate Environment and Public Works Committee, in a June reportaccompanying its version of the legislation, asserted that neither existing toxic chemical law nor any revisions pending in Congress should be seen as a way to “pre-empt, displace or supplant” the right to sue for damages in lawsuits like the ones filed against Monsanto.

The House also voted to preserve the right to sue if individuals or local governments believe they have been harmed by a chemical, regardless of future federal regulations of the substance. But a critical paragraph added to the House bill in late May made sure past regulatory requirements by the E.P.A. would continue to disqualify legal claims, and it specifically referred to the section of the 1976 toxic chemical law governing PCBs, giving Monsanto clearer authority in the future to ask judges to dismiss lawsuits filed against it.

Congressional aides involved in the drafting said the language was inserted at the request of Republican staff members at the House Energy and Commerce Committee. One Republican committee aide disputed any suggestion that this was a gift to Monsanto, but he said he was not allowed to discuss the issue on the record.

And Ms. Lord, the Monsanto spokeswoman, said the company did not ask for the change.

Read Full  Article – http://www.nytimes.com/2016/03/01/business/monsanto-could-benefit-from-a-chemical-safety-bill.html?_r=0

Woody Harrelson Applies to Open Marijuana Dispensary in Hawaii

Harrelson, 54, applied for a license in Honolulu County under his company, Simple Organic Living.

The Hawaii Department of Health posted the list of 66 applications on its website Friday. The state is now reviewing applications for dispensary permits, which they will award in April.

Video game entrepreneur Henk Rogers also applied for a license under his company, Blue Planet Foundation, which advocates for energy independence across the state. Rogers, 61, is famous for designing the video game “Tetris” more than 20 years ago, and lives in Hawaii in an entirely solar-powered home.

Among other applicants include Dirk Fukushima, producer of the local television show, “Hawaii Stars,” and former University of Hawaii Regent Charles Kawakami.

If selected, dispensary applicants must have $1 million cash before applying for a licenses, plus $100,000 for each dispensary location. All applicants must have been Hawaii residents for more than five years.

Under a law passed in 2015, the state will grant eight licenses for marijuana business owners across the islands. The law allows medical marijuana businesses to have two production centers and two retail dispensaries, for a total of 16 dispensaries statewide. Six are allowed on Oahu, four on Hawaii Island, four on Maui and two on Kauai.

Dispensaries are set to open in July.

Hawaii became the first to legalize medical marijuana through the legislative process 16 years ago. Lawmakers have introduced laws to legalize recreational marijuana; however they don’t think they’re likely to pass this year.

Sourced from – http://www.nbcnews.com/pop-culture/celebrity/woody-harrelson-applies-open-marijuana-dispensary-hawaii-n512641

Drug company leaders should face prosecution, Oregon official says

William Theobald, USA Today 12:12 p.m. PST February 23, 2016

WASHINGTON – Drug company executives should be prosecuted for improper actions that contribute to the growth of opioid addiction, an Oregon assistant attorney general told a Senate committee Tuesday.

“We have to have more personal accountability of the executives who make these decisions,” David Hart testified at a hearing of the Senate Finance Committee on the opioid addiction epidemic. “They can’t walk away with their stock options and their salaries.”

Hart, head of the Oregon attorney general’s health fraud unit, has led several investigations into improper marketing and promotion practices by pharmaceutical companies that make the highly addictive painkillers.

In response to questions from Sen. Ron Wyden, the ranking Democrat on the committee, Hart also said the companies should be required to forfeit the profit they earn from their improper actions.

“We need to have these companies help clean up the messes they make,” Hart said.

He cited the state’s investigation of Insys, the maker of a painkiller called Subsys. Investigators alleged the company provided “improper financial incentives” to doctors to increase prescriptions, promoted the drug to doctors not qualified to prescribe it, and deceptively promoted its use for mild pain.

The company agreed to a voluntary settlement last August that included a $1.1 million payment, which Hart said amounted to two times its sales of the drug in the state of Oregon. The money is being used to fight opioid addiction.

Hart also was involved in a 2007 settlement among Oregon and 26 other state attorneys general and Purdue Pharma, after the company was accused of misrepresenting OxyContin’s risk of addiction.

Wyden said one common theme he heard during public meetings in Oregon last week on opioid abuse was a phenomenon he dubbed the “prescription pendulum.”

In past years, he said, doctors were criticized for not being aggressive enough in prescribing medication to manage severe pain. Now, the issue has swung the other way and doctors are being criticized for overprescribing pain killers.

Oregon ranked fourth among states in the rate of abuse of prescription painkillers, according to a 2013-2014 survey by the federal Substance Abuse and Mental Health Services Administration. That’s down from first among the states in the same 2010-2011 survey.

Between 2000 and 2013, there were 2,226 deaths in Oregon due to opioid overdoses. While the overdose death rate has dropped in recent years, in 2013 it was still nearly three times the rate in 2000.

“This epidemic is carving a path of destruction through communities all across the country,” Wyden said.

He said he worries policymakers are splitting into opposing camps: one focused on increasing enforcement and the other favoring more resources for treatment.

“What’s needed is a better approach that includes three things: more prevention, better treatment, and tougher enforcement,” Wyden said. “True success will require all three to work in tandem.”

The committee is expected to take up legislation soon that would allow for people in the Medicare program who are identified as at-risk for opioid addiction to be placed in a special program under which all of their prescriptions would be handled by one doctor and/or one pharmacy. Opioid abusers often will obtain multiple prescriptions for the painkillers.

In 2013, 3.6 million prescriptions for opioid painkillers were dispensed in Oregon, enough for nearly one prescription for every resident.

U.S. legal marijuana sales were $5.4B in 2015, higher than Trump’s net worth and several times the cost of the Space Shuttle

NEW YORK DAILY NEWS
Wednesday, February 3, 2016, 9:15 PM
SETH PERLMAN/AP

Marijuana plants are shown at an Illinois medical marijuana cultivation center. Legal weed sales jumped 17% last year.

Americans spent more money on legal marijuana in 2015 than Donald Trump is worth, research revealed Monday.

The $5.4 billion in legal pot sales outpaces the magnate and presidential candidate’s $4.5 billion net worth and dwarfs the $1.7 billion cost of NASA’s Space Shuttle Endeavour. And weed sales will overtake the price of a nuclear-powered aircraft carrier in a few years.

Analysts from ArcView Market Research and New Frontier Data unveiled their annual report on the size of the legal pot market Monday, showing a 17% increase over 2014.

The marijuana market researchers predict overall sales will grow to $21.8 billion by 2020 at a compound annual rate of 30%. Voters in at least seven states will consider allowing adults to get high legally this year and 86% of Americans now live in states with some form of legal marijuana use.

Legal pot sales in U.S. outpaced The Donald’s $4.5 billion net worth.

“Many in the business and financial sector have taken a ‘wait and see’ approach to the legal cannabis industry,” the publishers wrote in an introductory letter. “The data in this report confirms what pioneer investors and entrepreneurs suspected: legalization of cannabis is one of greatest business opportunities of our time and it’s still early enough to see huge growth.”

Yet the figures already lend themselves to fun comparisons. They may never add up to the $710 billion Americans spend each year at bars and nightclubs or the $400 billion projected overall cost of the Department of Defense’s most costly and ambitious fighter jet program.

But the 2015 sales would buy 33 F-35 Joint Strike Fighters, based on the Government Accountability Office’s estimate. And when legal weed sales grow to $12 billion in 2018, the proceeds would be more than enough to pay for the city-sized USS John F. Kennedy aircraft carrier currently in the works.

Read Full Article – http://www.nydailynews.com/life-style/u-s-legal-marijuana-sales-5-4b-2015-article-1.2519611

How Misguided Drug Policies Are Failing the EDM Community

ON JANUARY 27, 2016, 9:00AM
 In 2002, a bipartisan group of three Republicans and four Democrats led by then-Senator Joe Biden responded to growing public concern about MDMA use. A flurry of legal pressure had risen from the drug-related death of 17-year-old Jillian Kirkland, who passed away after an evening at New Orleans’ State Palace Theatre in 1998. Nearly four years later, the Reducing Americans’ Vulnerability to Ecstasy Act, aka the R.A.V.E. Act, was referred to the Senate Committee on the Judiciary.
The loosely worded act was an extension of the 1986 “Crack House Statute,” under which promoters and event organizers could be charged with “maintain[ing] a drug-involved” premise. Wondering what that phrase actually means? So have US promoters, venue owners, advocates, artists, and fans since a slightly augmented act — the Illicit Drug Anti-Proliferation Act — was tacked onto a 2003 Amber Alert bill, which passed without a vote or much debate. Like most US drug policies, the act has hindered true harm reduction within club and festival culture.
During what has been reported as the plateau of MDMA use and resultant hospitalizations in the US, the DEA sent baby-faced undercover agent Michael Templeton to the site of Kirkland’s death to acquire a firsthand account of the environment and the interactions between club owners, drug dealers, and revelers. During a six-month period in early 2000, Templeton and a fellow DEA agent were able to, according to a Time report, purchase 45 hits of ecstasy. Instead of arresting any of their dealers, the DEA and the New Orleans Police Department gathered info to prosecute State Palace managers Robert and Brian Bruner, as well as promoter Donnie Estopinal, aka Disco Donnie.
The feds weren’t just building their case on the ecstasy hits, but the culture itself: uptempo beats, touching and massaging, glow sticks, availability of free water, and even the energetic style of dancing. “The country was a lot more conservative and much less open-minded,” remarks Estopinal via telephone about the era. “Scary times in this industry … [we] didn’t know who would be next.”
Unable to convict any party under the Crack House laws, the government pushed for new regulations that would allow for easier prosecution. By naming easy access to free water and “chill rooms” as indicators of drug-involved premises, authorities eliminated two primary harm reducers in order to make their next arrests. While the Illicit Drug Anti-Proliferation Act has yet to be used to successfully prosecute a single promoter or venue owner, the lack of those harm-reduction essentials has itself claimed multiple lives.
After heading to D.C.’s Echostage with some of her fellow University of Virginia Alpha Phi sorority sisters on August 30th, 2013, Shelley Goldsmith consumed unadulterated MDMA as many of her classmates had done since heading off to university. Later, she would succumb to hyperthermia, possibly to do excessive dehydration, and eventually die of cardiac arrest at the age of 19.
Eight months later, Shelley’s mother, Dede Goldsmith, would lead the collective efforts to Amend the R.A.V.E. Act. “In this situation, it became very clear that there is a problem with the law, but also a problem on college campuses in terms of identifying and supplying harm-reduction techniques for these substances just like there already is with alcohol,” says Goldsmith via phone.

Misinformation about MDMA is rampant. In contrast to underage drinking, little has been done at universities and colleges to properly educate young adults on the risks associated with club drugs. As Goldsmith points out, “[There are] organizations like SSDP (Students for Sensible Drug Policy) that work with more of an alternative crowd, but no one that really reaches out to Greek Life.” Given the increased risk of drug use within the US Greek system, that’s one communication gap that needs to be bridged.

 

“Everyone feels safe to come together around the drug war. ‘Those evil drugs, we gotta get ‘em,’” quips Multidisciplinary Association for Psychedelic Studies’ (MAPS) Policy and Advocacy Manager Natalie Ginsberg.

Even though we are nearly 50 years removed from the cultural renaissance that was 1968, politicians are still wary of the PR associated with progressive drug reform policies. While Senator Tim Kaine (D-VA) has assisted Goldsmith in officially connecting with the White House Office of National Drug Control Policy (ONDCP), and Goldsmith herself has been appointed to the Virginia Commission on Youth, no legislator has officially supported or introduced an amendment initiative. And Goldsmith doesn’t envision any campaigning politician to support the policy shift in the foreseeable future.

 

Full Article – http://consequenceofsound.net/2016/01/how-misguided-drug-policies-are-failing-the-edm-community/

Stay Up To Date With Legal News